Protocol › Definition · Last reviewed 2026-05-16
Definition
Summary
The Dutch Protocol is defined in the clinical literature as a phased, multidisciplinary treatment trajectory for adolescents with persistent, early-onset gender dysphoria. It comprises: (1) an extensive diagnostic psychological evaluation, (2) reversible suppression of endogenous puberty with GnRH agonists from Tanner stage 2, (3) cross-sex hormone therapy from around age 16, and (4) gender-affirming surgery from age 18.1
1. Clinical definition
The Dutch Protocol refers to the phased, multidisciplinary treatment pathway for adolescents with persistent, early-onset gender dysphoria as developed by Peggy Cohen-Kettenis, founder of the Utrecht gender clinic, who described the first case in 1998 and co-authored the 2006 article in which the protocol was further elaborated (source) (see origins). The protocol comprises:
- An extensive diagnostic phase with psychological and psychiatric assessment, carried out by a specialised multidisciplinary team.
- Reversible suppression of endogenous puberty with gonadotropin-releasing hormone agonists (GnRHa, typically triptorelin or leuprorelin) from Tanner stage 2.2
- Cross-sex hormone therapy (oestrogens or testosterone) from around age 16 (source).
- Gender-affirming surgery from age 18; the only exception is mastectomy, for which the Health Council says an indication can be given from age 16 (source).
For an extensive discussion of each phase see /protocol/the-three-phases/.
2. Distinguishing features
At the time of introduction, the Dutch Protocol distinguished itself from earlier approaches by:
- The application of puberty suppression as diagnostic space: freezing pubertal development to give the patient and treatment team time for evaluation.3
- Strict age and inclusion criteria, including a minimum age of 12 and life-long gender dysphoria that had increased around puberty (source).
- Exclusion of patients with serious comorbid psychiatric disorders that might interfere with the diagnostic process (source).
- A multidisciplinary set-up with involvement of endocrinologists, child psychiatrists, clinical psychologists and — where indicated — surgeons.
3. Terminological note
According to the Health Council, the treatment became known in the international literature as the Dutch Approach or the Dutch Protocol, and other countries adopted it with reference to that name. The Council notes that the term can refer both to the treatment with GnRH agonists and gender-affirming hormones and to the Dutch approach in a broad sense, and itself speaks of the Dutch care model (source).
Critical note
On the effects of puberty blockers, the Cass Review (2024) writes that the evidence on cognitive development and fertility is insufficient or contradictory, and several studies report lower bone density during treatment (source). The Health Council writes that biological puberty resumes when treatment is stopped, but that this does not mean all effects are reversible (source). In addition, a large majority of the young people who start go on to hormones: 125 of 143 (87 percent) in a Dutch study (source), 43 of 44 (98 percent) in a British study (source); according to the Cass Review there is no evidence that puberty blockers give time to think (source).4
See also
- Historical background: Origin VUmc
- Per treatment phase: The three phases
- Clinical criteria: Inclusion, Exclusion, Age / Tanner
- Primary sources: CK 1998, Delemarre 2006
- Terms (GnRHa, CSH, Tanner): Glossary
- People register — Cohen-Kettenis, Delemarre, de Vries.
- International comparison — how other countries handle this aspect.
- Timeline — context of protocol development.
- FAQ · For parents.
Footnotes
- de Vries ALC, Cohen-Kettenis PT. Clinical management of gender dysphoria in children and adolescents: the Dutch approach. J Homosex. 2012;59(3):301–20. doi:10.1080/00918369.2012.653300
- Delemarre-van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol. 2006;155(suppl 1):S131–7.
- Cohen-Kettenis PT, van Goozen SHM. Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. Eur Child Adolesc Psychiatry. 1998;7(4):246–8.
- Cass H. Independent review of gender identity services for children and young people: final report. NHS England; April 2024.